Clinical Trial Update: Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating obicetrapib in combination with ezetimibe as an adjunct to HIS therapy has completed, with results posted in July 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Obicetrapib (obicetrapib)

Snippet

Sponsor: NewAmsterdam Pharma | Conditions: Dyslipidemias, High Cholesterol | Phase 2 | Status: COMPLETED | Results posted: 2024-07-03